Impact of Humeral Component Version on Outcomes Following RTSA

Completed · Not applicable

Conditions studied: Rotator Cuff Tear Arthropathy

In brief

The proposed study is a prospective, single-blinded, randomized trial to investigate the impact of humeral component version on shoulder range of motion and patient reported functional outcomes following reverse total shoulder arthroplasty.

Key facts

Study ID

NCT03111147

Run by

Corewell Health East

People needed

95

Starts

2017-05-12

Expected to finish

2023-05-23

Last updated by the study team

2024-03-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing primary reverse total shoulder arthroplasty
• Diagnosis of cuff tear arthropathy or primary OA with RCT
• Intact posterior rotator cuff and subscapularis preoperatively, as determined by surgeon-administered physical exam
• 18 years or older

You may not qualify if…

• Revision arthroplasty
• Diagnosis of rheumatoid arthritis, infection, acute trauma or instability
• Minors (under 18 years of age)
• Prior open shoulder surgery
• Concomitant latissimus dorsi transfer
• Patients not undergoing a standard of care physical therapy protocol
• Pregnant, patient-reported
• Cognitively impaired

Where it is running

• Beaumont Health — Royal Oak, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.